EASL Education

@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement

[EASL Education @EASLedu]

⏬Download the Best of #EASLCongress Slide Decks on #EASLCampus!

These editable Slide Decks bring together the top selected abstracts from the Congress in each topic track. 📚

🔗https://t.co/5h8kEIvrnA

@EASLNews @CornbergMarkus @JasmohanBajaj @hlcortezpinto @Alexfornergon @horstef @SilviaAffo

#LiverX #BestOf

[EASL Education @EASLedu]

🤝 Module 5 of the EASL MASLD Guidelines Academy has begun in Pamplona!

21 nurses, allied health professionals and hepatologists have come together for two days of interactive, practice-focused learning.

Through clinical cases, role-play and hands-on training, they’ll explore how multidisciplinary care can strengthen patient-centred #MASLD management.

ℹ️https://t.co/xavoUzARin

#LiverX #MASLDacademy

@ClinicaNavarra @FrancqueSven @rabataller

[EASL Education @EASLedu]

✨The EASL MASLD Guidelines Academy 2026 starts today!

26 participants from 20 countries have come together in Angers for Module 1: The basics of MASLD, kicking off a five-module learning journey.

Over the next two days, they’ll explore everything from pathophysiology and epidemiology to screening, non-invasive tests and hands-on liver elastography.

The first step in a programme designed to turn the latest #MASLD guidance into practical clinical knowledge and skills.

Welcome to all our participants and faculty! 👏

ℹ️https://t.co/OFVRx2BF9a

#LiverX

[EASL Education @EASLedu]

🌍With more than 70 million people estimated to be living with chronic viral hepatitis, Africa faces a major liver health challenge.

This #TalkLiverToMe episode explores how viral hepatitis, rising metabolic liver disease, and gaps in prevention, surveillance, and access to care are shaping liver health across the continent.

More information below👇

@DebbieShawcros1 @ugbsofficial @Solda_Society #LiverX

[EASLnews @EASLnews]

Africa carries a major burden of liver disease but the crisis remains too often under-recognised.
That is why, in this episode, we address the drivers of liver disease across the continent, from viral hepatitis and MASLD to hepatocellular carcinoma, and ask what is needed to improve prevention, diagnosis, and care.
Listen on EASL Campus: https://t.co/BrwthhLdcd
Also on Spotify: https://t.co/Ulaytlz7ch
and Apple Podcasts: https://t.co/GAsNddbcAI

[EASLnews @EASLnews]

The EASL Schools 2027 applications are open! Four unique learning opportunities await you, including this School on Portal Hypertension (23-24 September 2027, Vienna, Austria).

The aim of this School is to foster a new generation of physicians and physician-scientists working in the field of ACLD/PSVD who are highly skilled in portal hypertension.

Organisers Lorenz Balcar, Annalisa Berzigotti, Virginia Hernández-Gea, Mattias Mandorfer and Thomas Reiberger are looking forward to meeting and exchanging with you!

Read more and submit your application by 28 September: https://t.co/Hia8UzDwmx

[EASLnews @EASLnews]

Test your guidelines knowledge as we explore today the case of a 32-year-old man who was referred for evaluation of elevated liver enzymes, hyperferritinaemia, and hepatic steatosis identified on ultrasound.

This EASL Quiz was developed in collaboration with ESPGHAN.

Play here: https://t.co/WpT8iEl9YH

[EASLnews @EASLnews]

On 27–28 August, the first module of the EASL MASLD Guidelines Academy 2026 brought together 26 participants from 20 countries in Angers, France. This programme is dedicated to supporting the implementation of MASLD guidelines in clinical practice and strengthening expertise across Europe and beyond.

#LiverTwitter #LiverX

[EASL Education @EASLedu]

🚨Happening tomorrow!🚨

Join us for an #EASLDeepDive exploring the role of genetic testing in Progressive Familial Intrahepatic Cholestasis (PFIC) from understanding genetic drivers and modern testing approaches to interpreting results in the clinical context.

Registration linke below👇

@KeitelVerena @VilarinhoSilvia @CholestasisDoc @MCarbone_80
#LiverX #Cholestatsis

[EASLnews @EASLnews]

Genetic testing is transforming the diagnostic approach to rare liver diseases.
In next week's webinar, discover how modern genomic technologies can support the diagnosis of #PFIC, how to navigate challenging genetic findings, and what emerging advances could mean for the future of hepatology. 🧬

📅 Wednesday 9 September 2026 at 18:00 CEST
🔗 https://t.co/ZEctCl0jcd

[EASLnews @EASLnews]

Do you have an idea for an innovative Clinical or Experimental & Translational Science EASL School? Successful proposals receive dedicated EASL funding and organisational support. Apply by 26 October!
Read more: https://t.co/0jLkxeTHko

[EASL Education @EASLedu]

Acute liver failure: what to do and what not to miss.

In this #TalkLiverToMe episode, experts discuss:

👉Acute liver injury vs acute liver failure
👉Acute-on-chronic liver failure and differential diagnosis
👉Key aetiologies and diagnostic essentials
👉Treatment options and early management
👉Transplant criteria, ICU care, and timely referral

@Mandorf1 @BavenoCoop @DebbieShawcros1 @KingsCollegeNHS @KingsCollegeLon @Inst_of_Liver

#LiverX #ACLF #ALF

[EASLnews @EASLnews]

What should clinicians prioritise in the critical early stages of acute liver failure, and what should be avoided?
Tune in to #TalkLivertoMe for a practical discussion on the dos and don’ts of ALF management, including recognition, initial work-up, escalation, and referral to specialist centres.
Now on EASL Campus: https://t.co/kgEyE6JIdu
Spotify: https://t.co/ieuVXAoO18
Apple Podcasts: https://t.co/5rpRnyQ7gw

[Mattias Mandorfer @MattiasMandorf1]

Talk Liver To Me on 🆘 Acute Liver Failure 🆘

▶️ALI vs. ALF vs. the differential ACLF
▶️Aetiologies around the 🌍 & workup
▶️NAC, NUCs & steroids
▶️Plasma exchange in 2026?
▶️Transplant criteria
▶️Transfer? Intubate? Coagulation?
▶️Futility

@EASLedu @LiverFellow #LiverTwitter

[Mattias Mandorfer @MattiasMandorf1]

👋 #LiverTwitter!
We're hosting an @EASLedu School on portal hypertension!
📰 @BavenoCoop VIII
👉ACLD & PSVD/vascular
👉Mastering NITs
👉Tips for TIPS
👉Case-based discussions
👉Live cases on HVPG - transjugular liver biopsy - EUS-PPG - EUS-guided liver biopsy

✨Apply now 👇

[EASLnews @EASLnews]

The first module of the EASL MASLD Guidelines Academy 2026 took place on 27–28 August in Angers, France, bringing together 26 participants from 20 countries.

Over two days, participants explored the fundamentals of MASLD, from pathophysiology and epidemiology to screening, non-invasive testing and risk stratification, complemented by practical workshops on liver elastography and the implementation of screening pathways.

Module 1 marks the first step in a five-module programme designed to translate MASLD guidelines into clinical practice.

#LiverTwitter #LiverX @EASLedu

[EASL Education @EASLedu]

📢The EASL Steatotic Liver Disease (SLD) Summit 2026 is now available on demand for all myEASL users!

Browse now all the event resources and catch up with the interactive discussions that took place in Budapest this year!🤩

🔗https://t.co/W3tXvg4S1t

#LiverX #SLDSummit

[EASL Education @EASLedu]

In the next #EASLDeepDive, explore how genetic testing can support the diagnosis of #PFIC, including:

🧬 Key genetic drivers
🔎 Modern testing approaches
🩺 Positioning testing in the diagnostic pathway
🧩 Interpreting findings in the clinical context

ℹ️https://t.co/NTJ2US5H0H

@KeitelVerena @VilarinhoSilvia @CholestasisDoc @MCarbone_80
#LiverX

[Mattias Mandorfer @MattiasMandorf1]

Bavevo VIII is online @JHepatology

🙏 to my panel co-chair @docberza & panellists @JuanAbraldes @EltonDajti @mathiasjachs @VWSWong et al

#LiverTwitter

Time for another @EASLedu Talk Liver To Me Episode, @tom_marjot ?

[EASL Education @EASLedu]

🔥Now available! 🔥

Endohepatology: added value or added complexity?

A #TalkLiverToMe podcast discussion in 5 parts:
1⃣EUS-guided liver biopsy
2⃣EUS-guided PPG measurement
3⃣New approaches to managing gastric varices
4⃣A one-stop shop for endoscopic liver assessment?
5⃣Where is the field is heading next?

@Tom_Marjot @JuanAbraldes @ESGE_news
#LiverX #Endohepatology

[EASLnews @EASLnews]

Endohepatology promises a more integrated approach to liver disease assessment.
But does combining EUS-guided biopsy, portal pressure measurement, and variceal evaluation in one session represent meaningful progress or premature adoption?

Listen to the latest #TalkLivertoMe to find out!

Now on EASL Campus: https://t.co/RbcLQOXOL0
Spotify: https://t.co/huccjx1EVo
Apple Podcasts: https://t.co/o7VKDEQvPp

[EASL Education @EASLedu]

#LiverX, where do you place yourself on the endohepatology adoption curve?

#TalkLiverTo

[EASL Education @EASLedu]

This week, #TalkLivertoMe will be focusing on endohapatology, an emerging field generating enthusiasm and debate.

Ahead of the upcoming episode, we want to know:
❓Where do you place yourself on the endohepatology adoption curve?

Vote in the poll below 👇

[EASLnews @EASLnews]

🚨 Applications are open for the EASL Mobility & Research Fellowship Programme!

Looking to advance your career in hepatology? EASL is supporting early- and mid-career professionals with two exciting 6-month fellowship opportunities:

🌍 Mobility Fellowships – Gain specialised skills and experience at another European institution while building international collaborations.

🔬 Research Fellowships – Conduct an impactful liver disease research project at your home institution.

If you're ready to expand your expertise and contribute to the future of hepatology, now is the time to apply.

Deadline: 1 September
More information: https://t.co/dWRGj6ij2d

[EASLnews @EASLnews]

Explore the future of liver cancer research and care at the EASL #LiverCancerSummit 2027!

📍 Valencia, Spain
📅 14 to 16 January 2027

Registration and abstract submission are now open.

Join a multidisciplinary community to discover the latest advances in primary liver cancer, from prevention and early detection to precision oncology, innovative treatments, and long term patient management.

Submit your research, connect with leading experts, and help shape the future of liver cancer care.

📅 7 August – 13 October, 2026: Abstract submission period

📅 7 August – 20 October, 2026: Early registration fees

👉 Learn more: https://t.co/ZoTzZafzem